Cas:24245-27-0 [amino(anilino)methylidene]-phenylazanium,chloride manufacturer & supplier

Chemical Name:[amino(anilino)methylidene]-phenylazanium,chloride

CAS.NO:24245-27-0

Synonyms:GUANIDINE,1,3-DIPHENYL-,MONOHYDROCHLORIDE;Diphenylguanidine hydrochloride;1,3-Diphenylguanidinium chloride;EINECS 246-107-8;Diphenylguanidinium chloride;N,N’-Diphenyl-guanidin,Hydrochlorid;N,N’-diphenylguanidine hydrochloride;Guanidine,N,N’-diphenyl-,monohydrochloride;N,N’-Diphenylguanidine monohydrochloride

Molecular Formula:C₁₃H₁₄ClN₃

Molecular Weight:247.72300

HS Code:2925290090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:364.3ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:47.91000

Exact Mass:247.08800

LogP:4.19310

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3077 9/PG 3

Packing Group:III

Contact us for information like GUANIDINE,1,3-DIPHENYL-,MONOHYDROCHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-Diphenylguanidine monohydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Guanidine,N,N’-diphenyl-,monohydrochloride Use and application,Diphenylguanidine hydrochloride technical grade,usp/ep/jp grade.

Related News: The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). [amino(anilino)methylidene]-phenylazanium,chloride manufacturer The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). [amino(anilino)methylidene]-phenylazanium,chloride supplier Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. [amino(anilino)methylidene]-phenylazanium,chloride vendor AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. [amino(anilino)methylidene]-phenylazanium,chloride factory She said she revealed her diagnosis in the interest of transparency but in truth really mostly as a shoutout to early diagnosis,” and wanted to “urge women to educate themselves on this disease; to get all the regular screenings and scans that you can; to always listen to your bodies; and of course to ensure that your legitimate medical concerns are not dismissed or diminished.